Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-2,504
Closed -$6.11K – 425
2024
Q3
$6.11K Hold
2,504
– – ﹤0.01% 536
2024
Q2
$5.13K Hold
2,504
– – ﹤0.01% 498
2024
Q1
$6.21K Hold
2,504
– – ﹤0.01% 531
2023
Q4
$7.01K Hold
2,504
– – ﹤0.01% 502
2023
Q3
$6.46K Buy
+2,504
New +$7.24K ﹤0.01% 631

Other funds holding ABEV

Operose Advisors's ABEV Position: Q4 2024 in Review

Operose Advisors sold out of Ambev (ABEV) in Q4 2024, closing a stake of 2,504 shares — an estimated $6.11K sold.

Operose Advisors first reported a position in ABEV in Q3 2023 and held it in 5 quarters. The position peaked at $7.01K in Q4 2023. 399 funds tracked by Wall St. Rank hold ABEV as of Q4 2024.

  • Operose Advisors reported no remaining Ambev position as of Q4 2024 after selling out during the quarter.
  • Operose Advisors sold 2,504 Ambev shares in Q4 2024, an estimated $6.11K.
  • Operose Advisors first reported a position in Ambev in Q3 2023 and held it in 5 quarters.
  • Operose Advisors's Ambev position peaked at $7.01K in Q4 2023.
  • 399 funds tracked by Wall St. Rank held Ambev as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.